{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:17:38Z","timestamp":1786112258931,"version":"build-2736575974"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,5]]},"DOI":"10.7759\/cureus.114010","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T14:46:32Z","timestamp":1785941192000},"source":"Crossref","is-referenced-by-count":0,"title":["Monogenic Familial Chylomicronemia Syndrome in Children: Clinical Divergences and Management Paradigms"],"prefix":"10.7759","author":[{"given":"Sin Yi Cindy","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Chung","family":"Yau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka Yee","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2025.03.013","article-title":"Familial chylomicronemia syndrome: an expert clinical review from the National Lipid Association","volume":"19","author":"Javed F","year":"2025","unstructured":"Javed F, Hegele RA, Garg A, et al.. Familial chylomicronemia syndrome: an expert clinical review from the National Lipid Association. J Clin Lipidol. 2025, 19:382-403. 10.1016\/j.jacl.2025.03.013","journal-title":"J Clin Lipidol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2018.03.093","article-title":"Clinical and biochemical features of different molecular etiologies of familial chylomicronemia","volume":"12","author":"Hegele RA","year":"2018","unstructured":"Hegele RA, Berberich AJ, Ban MR, et al.. Clinical and biochemical features of different molecular etiologies of familial chylomicronemia. J Clin Lipidol. 2018, 12:920-927.e4. 10.1016\/j.jacl.2018.03.093","journal-title":"J Clin Lipidol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2024.09.008","article-title":"Development and validation of clinical criteria to identify familial chylomicronemia syndrome (FCS) in North America","volume":"19","author":"Hegele RA","year":"2025","unstructured":"Hegele RA, Ahmad Z, Ashraf A, et al.. Development and validation of clinical criteria to identify familial chylomicronemia syndrome (FCS) in North America. J Clin Lipidol. 2025, 19:83-94. 10.1016\/j.jacl.2024.09.008","journal-title":"J Clin Lipidol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2018.04.010","article-title":"Familial chylomicronemia syndrome: bringing to life dietary recommendations throughout the\u00a0life span","volume":"12","author":"Williams L","year":"2018","unstructured":"Williams L, Rhodes KS, Karmally W, Welstead LA, Alexander L, Sutton L. Familial chylomicronemia syndrome: bringing to life dietary recommendations throughout the\u00a0life span. J Clin Lipidol. 2018, 12:908-919. 10.1016\/j.jacl.2018.04.010","journal-title":"J Clin Lipidol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2400201","article-title":"Olezarsen, acute pancreatitis, and familial chylomicronemia syndrome","volume":"390","author":"Stroes ES","year":"2024","unstructured":"Stroes ES, Alexander VJ, Karwatowska-Prokopczuk E, et al.. Olezarsen, acute pancreatitis, and familial chylomicronemia syndrome. N Engl J Med. 2024, 390:1781-1792. 10.1056\/NEJMoa2400201","journal-title":"N Engl J Med"},{"key":"ref6","unstructured":"Hong Kong Growth Study. A Guide to Hong Kong Growth Charts (HK2020 Growth References). Hong Kong. The Chinese University of Hong Kong and The University of Hong Kong; 2024. (2024). Accessed: July 14, 2026: https:\/\/www.cuhk.edu.hk\/proj\/hkgrowth\/."},{"key":"ref7","article-title":"Familial Hyperchylomicronemia Syndrome","author":"Regmi M","year":"2023","unstructured":"Regmi M, Rehman A. Familial Hyperchylomicronemia Syndrome. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-020-01302-x","article-title":"The burden of familial chylomicronemia syndrome in Canadian patients","volume":"19","author":"Gaudet D","year":"2020","unstructured":"Gaudet D, Stevenson M, Komari N, Trentin G, Crowson C, Hadker N, Bernard S. The burden of familial chylomicronemia syndrome in Canadian patients. Lipids Health Dis. 2020, 19:120. 10.1186\/s12944-020-01302-x","journal-title":"Lipids Health Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13016","article-title":"Familial chylomicronemia syndrome: an under-recognized cause of severe hypertriglyceridaemia","volume":"287","author":"Baass A","year":"2020","unstructured":"Baass A, Paquette M, Bernard S, Hegele RA. Familial chylomicronemia syndrome: an under-recognized cause of severe hypertriglyceridaemia. J Intern Med. 2020, 287:340-348. 10.1111\/joim.13016","journal-title":"J Intern Med"},{"key":"ref10","article-title":"Secondary hypertriglyceridemia","author":"Benuck I","year":"2000","unstructured":"Benuck I, Wilson DP, McNeal CJ. Secondary hypertriglyceridemia. In: Endotext [Internet]. MDText.com, Inc., South Dartmouth (MA); 2000."},{"key":"ref11","unstructured":"Practical Pearls. Primary Hypertriglyceridemia\u2014Treating Triglycerides When It\u2019s Not the Usual Suspects | National Lipid Association Online [Internet]. (2026). Accessed: August 4, 2026: https:\/\/www.lipid.org\/communications\/lipidspin\/2012FALL13."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-011-9406-5","article-title":"Deletion of GPIHBP1 causing severe chylomicronemia","volume":"35","author":"Rios JJ","year":"2012","unstructured":"Rios JJ, Shastry S, Jasso J, et al.. Deletion of GPIHBP1 causing severe chylomicronemia. J Inherit Metab Dis. 2012, 35:531-540. 10.1007\/s10545-011-9406-5","journal-title":"J Inherit Metab Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2016.04.013","article-title":"GPIHBP1 and plasma triglyceride metabolism","volume":"27","author":"Fong LG","year":"2016","unstructured":"Fong LG, Young SG, Beigneux AP, Bensadoun A, Oberer M, Jiang H, Ploug M. GPIHBP1 and plasma triglyceride metabolism. Trends Endocrinol Metab. 2016, 27:455-469. 10.1016\/j.tem.2016.04.013","journal-title":"Trends Endocrinol Metab"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2015.26","article-title":"Chylomicronaemia--current diagnosis and future therapies","volume":"11","author":"Brahm AJ","year":"2015","unstructured":"Brahm AJ, Hegele RA. Chylomicronaemia--current diagnosis and future therapies. Nat Rev Endocrinol. 2015, 11:352-362. 10.1038\/nrendo.2015.26","journal-title":"Nat Rev Endocrinol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/1744-9987.12008","article-title":"Severe hypertriglyceridemia-related acute pancreatitis","volume":"17","author":"Stefanutti C","year":"2013","unstructured":"Stefanutti C, Labbadia G, Morozzi C. Severe hypertriglyceridemia-related acute pancreatitis. Ther Apher Dial. 2013, 17:130-137. 10.1111\/1744-9987.12008","journal-title":"Ther Apher Dial"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/jca.22043","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue","volume":"38","author":"Connelly-Smith L","year":"2023","unstructured":"Connelly-Smith L, Alquist CR, Aqui NA, et al.. Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue. J Clin Apher. 2023, 38:77-278. 10.1002\/jca.22043","journal-title":"J Clin Apher"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/ejcn.2016.70","article-title":"Effects of two therapeutic dietary regimens on primary chylomicronemia in paediatric age: a retrospective data analysis","volume":"70","author":"Helk O","year":"2016","unstructured":"Helk O, Schreiber R, Widhalm K. Effects of two therapeutic dietary regimens on primary chylomicronemia in paediatric age: a retrospective data analysis. Eur J Clin Nutr. 2016, 70:1127-1131. 10.1038\/ejcn.2016.70","journal-title":"Eur J Clin Nutr"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000709","article-title":"Omega-3 fatty acids for the management of hypertriglyceridemia: a science advisory from the American Heart Association","volume":"140","author":"Skulas-Ray AC","year":"2019","unstructured":"Skulas-Ray AC, Wilson PW, Harris WS, et al.. Omega-3 fatty acids for the management of hypertriglyceridemia: a science advisory from the American Heart Association. Circulation. 2019, 140:e673-e691. 10.1161\/CIR.0000000000000709","journal-title":"Circulation"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(13)70191-8","article-title":"The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management","volume":"2","author":"Hegele RA","year":"2014","unstructured":"Hegele RA, Ginsberg HN, Chapman MJ, et al.. The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management. Lancet Diabetes Endocrinol. 2014, 2:655-666. 10.1016\/S2213-8587(13)70191-8","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1715944","article-title":"Volanesorsen and triglyceride levels\u00a0in familial chylomicronemia syndrome","volume":"381","author":"Witztum JL","year":"2019","unstructured":"Witztum JL, Gaudet D, Freedman SD, et al.. Volanesorsen and triglyceride levels\u00a0in familial chylomicronemia syndrome. N Engl J Med. 2019, 381:531-542. 10.1056\/NEJMoa1715944","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab820","article-title":"Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk","volume":"43","author":"Tardif JC","year":"2022","unstructured":"Tardif JC, Karwatowska-Prokopczuk E, Amour ES, et al.. Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk. Eur Heart J. 2022, 43:1401-1412. 10.1093\/eurheartj\/ehab820","journal-title":"Eur Heart J"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.039107","article-title":"Inhibition of angiopoietin-like protein 3 with a monoclonal antibody reduces triglycerides in hypertriglyceridemia","volume":"140","author":"Ahmad Z","year":"2019","unstructured":"Ahmad Z, Banerjee P, Hamon S, et al.. Inhibition of angiopoietin-like protein 3 with a monoclonal antibody reduces triglycerides in hypertriglyceridemia. Circulation. 2019, 140:470-486. 10.1161\/CIRCULATIONAHA.118.039107","journal-title":"Circulation"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.12997\/jla.2026.15.1.72","article-title":"Olezarsen and beyond: emerging targeted treatments for familial chylomicronemia syndrome and related triglyceride disorders","volume":"15","author":"N M","year":"2026","unstructured":"N M, C B K, D R S. Olezarsen and beyond: emerging targeted treatments for familial chylomicronemia syndrome and related triglyceride disorders. J Lipid Atheroscler. 2026, 15:72-87. 10.12997\/jla.2026.15.1.72","journal-title":"J Lipid Atheroscler"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/515216-monogenic-familial-chylomicronemia-syndrome-in-children-clinical-divergences-and-management-paradigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T14:46:35Z","timestamp":1785941195000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/515216-monogenic-familial-chylomicronemia-syndrome-in-children-clinical-divergences-and-management-paradigms"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.114010","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,5]]}}}